Stay updated on Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page.

Latest updates to the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a Phase 3 study on Ibrexafungerp and the addition of a new revision number. The specific study details regarding inclusion and exclusion criteria have been deleted, which may impact the understanding of the study's scope.SummaryDifference16%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page.